Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SEP-225289 in Major Depressive Disorder
NCT00584974Phase 2Completed
- Sponsor
- Sumitomo Pharma America
- Start
- Dec 2007
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dasotraline in major depressive disorder (MDD), sponsored by Sumitomo Pharma America. Started Dec 2007; status: completed.
02
Drugs
dasotraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00584974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00584974.